Among the four groups, participants in T2D‐NO had the lowest homeostasis model assessment of insulin secretion (HOMA‐% B), first‐phase insulin release (1st PH) and second‐phase insulin release (2nd PH), suggesting dysfunction of insulin secretion (Figure 1B–H). The gene discussed is INS; the disease is type 2 diabetes mellitus.